Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions

被引:0
|
作者
Yao, Yingsha [1 ]
Shi, Liujing [1 ]
Zhu, Xiaoming [1 ,2 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Key Lab Womens Reprod Hlth Zhejiang Prov, Hangzhou 310006, Peoples R China
关键词
polycystic ovary syndrome; endometrial proliferative lesions; anti-Mullerian hormone; threshold value; regression model; POLYCYSTIC-OVARY-SYNDROME; CANCER STATISTICS; RISK; HYPERPLASIA; ULTRASOUND; PREDICTION; CONSENSUS; CRITERIA; CA125; HE-4;
D O I
10.3390/diagnostics13213301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endometrial proliferative lesions (EPL) usually refer to endometrial hyperplasia (EH) and endometrial cancer (EC). Among patients with premenopausal EPL who wish to preserve their fertility, only those with EH and early-stage EC have the possibility to undergo fertility preservation therapy. However, there is currently a lack of specific and reliable screening criteria and models for identifying these patients. Methods: This study utilized a retrospective diagnostic study design. The training set included medical record information that met the criteria between August 2017 and October 2022, while the validation set consisted of medical record information that met the criteria from November 2022 to May 2023. The endometrial pathological test served as the gold standard. The serum anti-Mullerian hormone (AMH) level before endometrial sampling and a regression model were employed to predict EPL. Results: The study included a total of 1209 patients with PCOS (1119 in the control group and 90 in the endometrial proliferative lesion group) and 5366 women without PCOS (5249 in the control group and 117 in the proliferative lesion group). In the case of PCOS patients aged 20-39 years, the most effective screening threshold for AMH was found to be a serum AMH level of <= 5.39 ng/mL. The model used for this group was logit(p) = -2.562 - 0.430 x AMH + 0.127 x BMI + 1.512 x hypertension + 0.956 x diabetes -1.145 x regular menstruation. On the other hand, for non-PCOS women aged 20-39 years, the optimal screening threshold for AMH was determined to be a serum AMH value of <= 2.18 ng/mL. The model used for this group was logit(p) = -3.778 - 0.823 x AMH + 0.176 x BMI + 2.660 x diabetes -1.527 x regular menstruation -1.117 x dysmenorrhea. It is important to note that all of these findings have successfully passed internal verification. Conclusion: For PCOS and non-PCOS women aged 20-39 years, the serum AMH test and related multiple regression models were obtained for the warning of EPL.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Clinical application of serum anti-Mullerian hormone in women
    Oh, So Ra
    Choe, Sun Yi
    Cho, Yeon Jean
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2019, 46 (02): : 50 - 59
  • [42] Association of Endometrioma Size with Serum Anti-mullerian Hormone
    Akgul, Ozlem Karabay
    Guraslan, Hakan
    Kovalak, Evrim Ebru
    Karacan, Tolga
    Aydin, Tugba Ozcan
    Cay, Tugce
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1132 - 1136
  • [43] Correlation of serum anti-mullerian hormone levels with serum follicular stimulating hormone, luteinizing hormone and testosterone levels in male patients of depression
    Shamsi, Nasar Abbas
    Ambreen, Shazadi
    Ayaz, Hira
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (03) : 476 - 479
  • [44] ANTI-MULLERIAN HORMONE LEVELS AND ART OUTCOMES.
    Vaughan, D. A.
    Harrity, C.
    FERTILITY AND STERILITY, 2015, 104 (03) : E251 - E251
  • [45] Anti-Mullerian Hormone Levels and Risk of Cancer in Women
    Verdiesen, Renee M. G.
    van Gils, Carla H.
    Stellato, Rebecca K.
    Verschuren, W. M. Monique
    Broekmans, Frank J. M.
    de Kat, Annelien C.
    van der Schouw, Yvonne T.
    Onland-Moret, N. Charlotte
    MATURITAS, 2021, 143 : 216 - 222
  • [46] Anti-Mullerian Hormone Levels among Female Firefighters
    Davidson, Samantha
    Jahnke, Sara
    Jung, Alesia M.
    Burgess, Jefferey L.
    Jacobs, Elizabeth T.
    Billheimer, Dean
    Farland, Leslie V.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
  • [48] Skeletal maturity influences anti-Mullerian hormone levels
    Ford, McKenzie L.
    Choh, Audrey C.
    Gonzalez, Brandon
    Lindheim, Steven R.
    Stanczyk, Frank Z.
    McGinnis, Linda K.
    Czerwinski, Stefan A.
    AMERICAN JOURNAL OF HUMAN BIOLOGY, 2022, 34
  • [49] Are Anti-Mullerian Hormone Levels Predictive of Aneuploidy Rates?
    Kort, Johnathan
    Lathi, Ruth
    Zhao, Qianying
    Behr, Barry
    Baker, Valerie
    FERTILITY AND STERILITY, 2014, 101 (02) : E5 - E6
  • [50] Anti-mullerian hormone levels predict ovarian morphology
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (01) : 16 - 16